Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01311973 · ClinicalTrials.gov registry record
Salivary Phosphorus and Level of Kidney Function
A clinical trial, sponsored by Denver Nephrologists, P.C..
- Completed
- Registry status
- 105
- Enrollment target
NCT01311973: Completed study, sponsored by Denver Nephrologists, P.C..
NCT01311973 is a clinical trial that has completed, run by Denver Nephrologists, P.C.. The registered enrollment target is 105 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01311973 has completed, sponsored by Denver Nephrologists, P.C..
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
The specific purpose of this study is to describe the relationship between salivary phosphorus and kidney function, specifically as it relates to serum phosphorus, FGF23, PTH, vitamin D status and urinary excretion of phosphorus.
Primary Outcome
subjects with various levels of estimated glomerular filtration rate will have a single assessment in the fasted state of salivary phosphorus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-07 |
What the finished NCT01311973 record still lists
NCT01311973 is an observational study that tracks outcomes without assigning an intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01311973 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01311973 about?
NCT01311973 is a clinical study titled "Salivary Phosphorus and Level of Kidney Function". The specific purpose of this study is to describe the relationship between salivary phosphorus and kidney function, specifically as it relates to serum phosphorus, FGF23, PTH, vitamin D status and urinary excretion of phosphorus.
What is the current status of trial NCT01311973?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2011-03. Estimated completion is 2011-07.
Who is sponsoring clinical trial NCT01311973?
This trial is sponsored by Denver Nephrologists, P.C., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia